Endocrinologist Audio From Hot Topics in NASH: Emerging Treatment Approaches

Listen as expert endocrinologist faculty discuss agents in late-phase clinical trials and their potential use in treatment.
Juan Pablo Frias, MD, FACE
Format: Audio (.mp3)
File Size: 37.9 MB
Released: February 5, 2020

Acknowledgements

Provided by the American Gastroenterology Association.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Endocrine Society Logo
Supported by educational grants from
Allergan
Gilead Sciences
Intercept Pharmaceuticals, Inc.

Related Content

Expert insights on emerging NAFLD/NASH treatments from Dr. Stephen Harrison and Clinical Care Options (CCO)

Stephen Harrison, MD, FACP, FAASLD, COL (ret.) USA, MC Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: September 17, 2021 Expired: September 16, 2022

Video from CCO and Dr. Stephen Harrison highlighting take-home points about pathogenesis, risk, and treatment of NAFLD/NASH from the NASH Core Curriculum

Stephen Harrison, MD, FACP, FAASLD, COL (ret.) USA, MC Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: September 9, 2021 Expired: September 8, 2022

Downloadable slides from CCO and Dr. Stephen Harrison highlighting take-home points about pathogenesis, risk, and treatment of NAFLD/NASH from the NASH Core Curriculum

Stephen Harrison, MD, FACP, FAASLD, COL (ret.) USA, MC Released: September 9, 2021

From Clinical Care Options (CCO) and Global Liver Institute: Easy-to-read reminders on why and how to look for NAFLD and NASH in your patients: FIB-4, VCTE, MRE, and more

Released: August 6, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue